Literature DB >> 9317034

Haemophilus somnus immunoglobulin binding proteins and surface fibrils.

L B Corbeil1, F D Bastida-Corcuera, T J Beveridge.   

Abstract

The high-molecular-weight (HMW) immunoglobulin binding proteins (IgBPs) of Haemophilus somnus and a 76-kDa surface protein (p76) are found in serum-resistant virulent strains but not in several serum-sensitive strains from asymptomatic carriers. For the first time, p76 was shown to be an IgBP also. This was done by competitive inhibition studies with affinity-purified antidinitrophenol (anti-DNP) and DNP to ensure that binding was not antigen specific. The HMW IgBPs, but not the p76 IgBP, were partially purified from concentrated culture supernatant in detergent by fluid-phase liquid chromatography with a gel filtration column. Membrane extraction studies showed that p76 predominated in the Sarkosyl-soluble fraction of the bacterial cell pellet. Since integral outer membrane (OM) proteins are Sarkosyl insoluble, this is consistent with our previous finding that implicated p76 as a peripheral OM protein. The HMW IgBPs were found predominantly in the Sarkosyl-soluble fraction of the culture supernatant. This suggests that they were not integral membrane proteins and that their presence in the supernatant was not due to OM blebbing. We then showed that two IgBP-positive serum-resistant virulent strains have a surface fibrillar network but that two IgBP-negative serum-sensitive H. somnus strains from asymptomatic preputial carriers do not. Fibrils on the surfaces of IgBP+ strains bound gold-labelled bovine immunoglobulin G2 (IgG2) anti-DNP, indicating that these fibrils have IgG2 binding activity. Therefore, this study shows that H. somnus has two IgBPs, including a peripheral membrane protein and a fibrillar surface network.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317034      PMCID: PMC175610          DOI: 10.1128/iai.65.10.4250-4257.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

Authors:  D Pilz; T Vocke; J Heesemann; V Brade
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 2.  Complement evasion by bacteria and parasites.

Authors:  K A Joiner
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

3.  Immunoglobulin binding by the regular surface array of Aeromonas salmonicida.

Authors:  B M Phipps; W W Kay
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

4.  Acellular pertussis vaccine hailed for infants.

Authors:  C Marwick
Journal:  JAMA       Date:  1995-08-09       Impact factor: 56.272

5.  Virulence differences among three strains of Haemophilus somnus following intratracheal inoculation of calves.

Authors:  S C Groom; P B Little; S Rosendal
Journal:  Can J Vet Res       Date:  1988-07       Impact factor: 1.310

6.  Cloning and expression of genes encoding Haemophilus somnus antigens.

Authors:  L B Corbeil; G Chikami; M Yarnall; J Smith; D G Guiney
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Purification and characterization of lipooligosaccharides from four strains of "Haemophilus somnus".

Authors:  T J Inzana; B Iritani; R P Gogolewski; S A Kania; L B Corbeil
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

8.  Antibody response to Haemophilus somnus Fc receptor.

Authors:  M Yarnall; L B Corbeil
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

9.  Protective ability and specificity of convalescent serum from calves with Haemophilus somnus pneumonia.

Authors:  R P Gogolewski; S A Kania; T J Inzana; P R Widders; H D Liggitt; L B Corbeil
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

10.  Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats.

Authors:  C Gripenberg-Lerche; M Skurnik; L Zhang; K O Söderström; P Toivanen
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more
  16 in total

1.  Histophilus somni IbpA DR2/Fic in virulence and immunoprotection at the natural host alveolar epithelial barrier.

Authors:  Bereket Zekarias; Seema Mattoo; Carolyn Worby; Jason Lehmann; Ricardo F Rosenbusch; Lynette B Corbeil
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

2.  Mutations in the lspA1 and lspA2 genes of Haemophilus ducreyi affect the virulence of this pathogen in an animal model system.

Authors:  Christine K Ward; Jo L Latimer; Joseph Nika; Merja Vakevainen; Jason R Mock; Kaiping Deng; Robert J Blick; Eric J Hansen
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells.

Authors:  E Behling-Kelly; H Vonderheid; Kwang Sik Kim; L B Corbeil; C J Czuprynski
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

4.  Characterization of putative Haemophilus somnus isolates from tonsils of American bison (Bison bison).

Authors:  A C Ward; N W Dyer; L B Corbeil
Journal:  Can J Vet Res       Date:  1999-07       Impact factor: 1.310

5.  Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro.

Authors:  M J Sylte; L B Corbeil; T J Inzana; C J Czuprynski
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Platelet activation by Histophilus somni and its lipooligosaccharide induces endothelial cell proinflammatory responses and platelet internalization.

Authors:  Christopher J Kuckleburg; Dave J McClenahan; Charles J Czuprynski
Journal:  Shock       Date:  2008-02       Impact factor: 3.454

7.  Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.

Authors:  Diane M Janowicz; Kate R Fortney; Barry P Katz; Jo L Latimer; Kaiping Deng; Eric J Hansen; Stanley M Spinola
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Protection of mice against H. somni septicemia by vaccination with recombinant immunoglobulin binding protein subunits.

Authors:  Roger S Geertsema; Carolyn Worby; Robert P Kruger; Yuichi Tagawa; Riccardo Russo; D Scott Herdman; Kimby Lo; Richard A Kimball; Jack Dixon; Lynette B Corbeil
Journal:  Vaccine       Date:  2008-06-30       Impact factor: 3.641

9.  Molecular characterization of phosphorylcholine expression on the lipooligosaccharide of Histophilus somni.

Authors:  Shaadi F Elswaifi; Frank St Michael; Avula Sreenivas; Andrew Cox; George M Carman; Thomas J Inzana
Journal:  Microb Pathog       Date:  2009-08-12       Impact factor: 3.738

10.  Characterization and comparison of biofilm development by pathogenic and commensal isolates of Histophilus somni.

Authors:  Indra Sandal; Wenzhou Hong; W Edward Swords; Thomas J Inzana
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.